Responses
Regular and Young Investigator Award Abstracts
Clinical Trials Completed
608 Predicting primary resistance and exploring mechanisms in patients with advanced melanoma treated with immune checkpoint inhibitors (ICIs)
Compose a Response to This Article
Other responses
No responses have been published for this article.